See more : White River Energy Corp. (WTRV) Income Statement Analysis – Financial Results
Complete financial analysis of The Valens Company Inc. (VLNS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of The Valens Company Inc., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Shenzhen Expressway Corporation Limited (600548.SS) Income Statement Analysis – Financial Results
- Future Care Trading Co. (9544.SR) Income Statement Analysis – Financial Results
- Vinergy Capital Inc. (VIN.CN) Income Statement Analysis – Financial Results
- Sanyu Co., Ltd. (5697.T) Income Statement Analysis – Financial Results
- Global Water Technologies, Inc. (GWTR) Income Statement Analysis – Financial Results
The Valens Company Inc. (VLNS)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.thevalenscompany.com
About The Valens Company Inc.
The Valens Company Inc. develops, manufactures, and sells cannabinoid-based products in Canada and internationally. It produces dried cannabis and hemp biomass products. The company also provides a range of products, including tinctures, two-piece caps, soft gels, oral sprays, and vape pens, as well as beverages, concentrates, topicals, edibles, natural health, and other products. In addition, it offers CO2, ethanol, hydrocarbon, solvent-less and terpene extraction, analytical testing, formulation, product development, and custom manufacturing services. The company was formerly known as Valens Groworks Corp. and changed its name to The Valens Company Inc. in June 2020. The Valens Company Inc. is headquartered in Toronto, Canada.
The Valens Company says shareholders overwhelmingly vote in favour of takeover by SNDL
Is SNDL Stock a Buy Now?
The Valens Company receives sales licence amendment from Health Canada for its Pommies manufacturing facility
Stifel GMP analysts repeat ‘Buy' rating and C$1.20 price target for The Valens Company on robust 3Q results
The Valens Company reports higher 3Q adjusted gross profit as integration initiatives kick in
Does SNDL's Latest Acquisition Make the Stock a Buy?
Has This Growth Stock Turned Its Business Around?
The Valens Company remains an 'attractive risk-adjusted opportunity' following acquisition announcement according to Stifel GMP analysts
Source: https://incomestatements.info
Category: Stock Reports